TIM-3 therapy for Alzheimer’s is gaining attention as a promising approach to combat the cognitive decline associated with this pervasive neurodegenerative disease.Recent research indicates that by targeting the TIM-3 checkpoint molecule, we can enhance the ability of microglia, the brain's immune cells, to clear harmful amyloid plaques.